New form of Taxol approved.
Bristol-Myers Squibb’s Taxol and Sanofi-Aventis’ Taxotere have new competition with the approval of American Pharmaceutical Partners' Abraxane for advanced breast ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.